Codiak BioSciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.80
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.82
|
-0.77
|
0.05
|
6.10%
|
|
2022-06-30
|
-0.84
|
-0.30
|
0.54
|
64.29%
|
|
2022-03-31
|
-0.89
|
-0.36
|
0.53
|
59.55%
|
|
2021-12-31
|
-0.94
|
0.74
|
1.68
|
178.72%
|
|
2021-09-30
|
-0.94
|
-0.97
|
-0.03
|
-3.19%
|
|
2021-06-30
|
-1.05
|
-0.99
|
0.06
|
5.71%
|
|
2021-03-31
|
-1.09
|
-0.51
|
0.58
|
53.21%
|
|
2020-12-31
|
-1.54
|
-1.14
|
0.40
|
25.97%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.43
|
|
2021-12-31
|
-1.73
|
|
2020-12-31
|
-20.83
|